ALPS Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,631
Closed -$444K – 1245
2026
Q2
$444K Buy
4,631
+45
+1% +$4.61K ﹤0.01% 1023
2026
Q1
$501K Sell
4,586
-405
-8% -$38.6K ﹤0.01% 823
2025
Q4
$405K Buy
4,991
+55
+1% +$4.74K ﹤0.01% 887
2025
Q3
$432K Buy
4,936
+664
+16% +$59.3K ﹤0.01% 868
2025
Q2
$355K Buy
4,272
+52
+1% +$4.35K ﹤0.01% 859
2025
Q1
$354K Buy
+4,220
New +$393K ﹤0.01% 769
2022
Q1
– Sell
-6,469
Closed -$325K – 908
2021
Q4
$325K Buy
6,469
+130
+2% +$6.72K ﹤0.01% 814
2021
Q3
$337K Sell
6,339
-1,206
-16% -$67.9K ﹤0.01% 812
2021
Q2
$460K Hold
7,545
– – ﹤0.01% 529
2021
Q1
$368K Buy
+7,545
New +$354K ﹤0.01% 535
2019
Q3
– Sell
-12,775
Closed -$357K – 922
2019
Q2
$357K Sell
12,775
-674
-5% -$18.7K ﹤0.01% 766
2019
Q1
$417K Buy
13,449
+249
+2% +$6.64K ﹤0.01% 610
2018
Q4
$312K Sell
13,200
-657
-5% -$17.9K ﹤0.01% 782
2018
Q3
$537K Buy
13,857
+1,434
+12% +$51.7K ﹤0.01% 547
2018
Q2
$416K Sell
12,423
-584
-4% -$20.8K ﹤0.01% 746
2018
Q1
$471K Buy
13,007
+700
+6% +$24.2K ﹤0.01% 593
2017
Q4
$392K Buy
12,307
+1
+0% +$34 ﹤0.01% 683
2017
Q3
$460K Sell
12,306
-8,641
-41% -$294K ﹤0.01% 648
2017
Q2
$654K Buy
20,947
+54
+0.3% +$1.56K ﹤0.01% 314
2017
Q1
$515K Buy
+20,893
New +$491K ﹤0.01% 380

Other funds holding LMAT

ALPS Advisors's LMAT Position: Q3 2026 in Review

ALPS Advisors sold out of LeMaitre Vascular (LMAT) in Q3 2026, closing a stake of 4,631 shares — an estimated $444K sold.

ALPS Advisors first reported a position in LMAT in Q1 2017 and held it in 20 quarters. The position peaked at $654K in Q2 2017. 104 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • ALPS Advisors reported no remaining LeMaitre Vascular position as of Q3 2026 after selling out during the quarter.
  • ALPS Advisors sold 4,631 LeMaitre Vascular shares in Q3 2026, an estimated $444K.
  • ALPS Advisors first reported a position in LeMaitre Vascular in Q1 2017 and held it in 20 quarters.
  • ALPS Advisors's LeMaitre Vascular position peaked at $654K in Q2 2017.
  • 104 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on ALPS Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.